Latest News
Higher Dosages of IV Epoprostenol Needed for Clinical Benefit in Severe PAH
Pooled Study Data Indicate Benefits of Early Selexipag Initiation in PAH
Echocardiography Could Improve Stratification of Mortality Risk in PAH
Study Determines Minimal Clinically Important Difference in 6MWD for PAH
Volume Status and Cardiac Findings Predict sPAP in Patients With PAH
β3 Adrenergic Receptor Agonists May Be Effective as PAH Treatment
Decreased Mortality Seen With Anti-U1 RNP Antibodies in CTD-Related PAH
Exhaled Air Metabolome Analysis Reveals a Range of PAH Biomarkers
Ambrisentan Shows Similar Pharmacokinetic Profiles in Pediatric and Adult PAH
PAH Patients Seem to Adhere Better to Inhaled Treprostinil Than to Iloprost
Considerable Treatment Discontinuation Reported in Patients With PAH
Latest Clinical Trials
Insights
Is Gut Microbiota Involved in Pulmonary Arterial Hypertension?
Recent research has uncovered unexpected links between gut microbiota and pulmonary arterial hypertension.
Improving Risk Stratification in Pulmonary Arterial Hypertension
Researchers propose a new model for risk stratification in pulmonary arterial hypertension encompassing four risk categories.
Being Pregnant With PAH: Management and Risks
Pregnant women with pulmonary arterial hypertension experience certain risks that require close monitoring.
How PAH Demonstrates the Interconnectivity of Medicine
Many diseases, including pulmonary arterial hypertension, cut across various medical specialties and require multidisciplinary cooperation.
Diagnosing and Treating Pulmonary Arterial Hypertension in Geriatric Patients
Pulmonary arterial hypertension, once considered a disease of the young, is increasingly affecting patients of older age.
PAH Patient Perspectives
Should I Have Another Catheterization for My Pulmonary Arterial Hypertension?
I live with pulmonary arterial hypertension (PAH), a progressive rare disease that is treated by addressing the symptoms only and not the disease.
For This PAH Patient, Curves and Detours on the Road to Diagnosis
In the summer of 2015, I had started to feel early symptoms of what would become a diagnosis of pulmonary arterial hypertension (PAH).
Rare Care Podcast
Noah Greenspan, DPT, founder of New York City’s Pulmonary Wellness & Rehabilitation Center, runs the nonprofit Pulmonary Wellness Foundation. In this interview, he talks about diagnosing and treating pulmonary arterial hypertension.
PAH Features
Ambitious NCATS Bespoke Gene Therapy Consortium Targets Ultrarare Diseases
The Bespoke Gene Therapy Consortium (BGTC) is an ambitious public-private partnership that aims to develop gene therapies for ultrarare diseases.
An Inspirational Feat: Crossing Spain’s 500-Mile Camino de Santiago by Wheelchair
When 2 friends set out along Spain’s 500-mile Camino de Santiago, they didn’t know how many people they’d inspire with 3 little words: “I’ll Push You.”
Aytu BioPharma’s Healight Device Could Help Treat Rare Pulmonary Diseases
Aytu BioPharma has developed an endotracheal respiratory catheter which its CEO says has “tremendous potential” in IPF, PAH, and other respiratory diseases.
Israel Emerges as Global Powerhouse in Rare Disease Research
When it comes to rare disorders, Israel—a New Jersey-sized nation of 9.3 million that’s made headlines this year for its highly successful coronavirus vaccination campaign—is clearly an emerging powerhouse.
PAH Meeting Coverage
- Loading...
Loading...
Loading... 
Loading...